As of 2025-04-19, the Relative Valuation of BioXcel Therapeutics Inc (BTAI) is (143.28) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of BioXcel Therapeutics Inc based on Relative Valuation is -7972.4%.
The range of the Relative Valuation is (89.34) - (218.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 23.0x | 13.6x |
| Forward P/E multiples | 7.7x - 20.1x | 12.7x |
| Fair Price | (89.34) - (218.57) | (143.28) |
| Upside | -5009.0% - -12109.1% | -7972.4% |
| Date | P/E |
| 2025-04-15 | -0.17 |
| 2025-04-14 | -0.18 |
| 2025-04-11 | -0.17 |
| 2025-04-10 | -0.15 |
| 2025-04-09 | -0.16 |
| 2025-04-08 | -0.13 |
| 2025-04-07 | -0.14 |
| 2025-04-04 | -0.15 |
| 2025-04-03 | -0.17 |
| 2025-04-02 | -0.18 |
| 2025-04-01 | -0.18 |
| 2025-03-31 | -0.19 |
| 2025-03-28 | -0.19 |
| 2025-03-27 | -0.21 |
| 2025-03-26 | -0.20 |
| 2025-03-25 | -0.21 |
| 2025-03-24 | -0.21 |
| 2025-03-21 | -0.21 |
| 2025-03-20 | -0.22 |
| 2025-03-19 | -0.22 |
| 2025-03-18 | -0.20 |
| 2025-03-17 | -0.21 |
| 2025-03-14 | -0.20 |
| 2025-03-13 | -0.21 |
| 2025-03-12 | -0.22 |
| 2025-03-11 | -0.23 |
| 2025-03-10 | -0.27 |
| 2025-03-07 | -0.31 |
| 2025-03-06 | -0.25 |
| 2025-03-05 | -0.25 |
| 2025-03-04 | -0.25 |
| 2025-03-03 | -0.34 |
| 2025-02-28 | -0.20 |
| 2025-02-27 | -0.16 |
| 2025-02-26 | -0.17 |
| 2025-02-25 | -0.17 |
| 2025-02-24 | -0.18 |
| 2025-02-21 | -0.20 |
| 2025-02-20 | -0.21 |
| 2025-02-19 | -0.22 |
| 2025-02-18 | -0.21 |
| 2025-02-14 | -0.21 |
| 2025-02-13 | -0.22 |
| 2025-02-12 | -0.26 |
| 2025-02-11 | -0.23 |
| 2025-02-10 | -0.27 |
| 2025-02-07 | -0.24 |
| 2025-02-06 | -0.27 |
| 2025-02-05 | -0.44 |
| 2025-02-04 | -0.42 |